{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:49:00Z","timestamp":1767649740442,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.purol.2017.09.009","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T14:04:09Z","timestamp":1521209049000},"page":"291-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cryoth\u00e9rapie prostatique de rattrapage apr\u00e8s \u00e9chec de radioth\u00e9rapie externe ou curieth\u00e9rapie\u00a0: morbidit\u00e9 et r\u00e9sultats oncologiques \u00e0 moyen terme"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Gevorgyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"H\u00e9tet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Duchattelle-Dussaule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Corno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Boulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20\u00a0Suppl","key":"10.1016\/j.purol.2017.09.009_bib0005","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S1166-7087(10)70041-5","article-title":"Incidence et mortalit\u00e9 projet\u00e9es des cancers urologiques en 2010","volume":"4","author":"Rebillard","year":"2010","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.purol.2017.09.009_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"European association of urology","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2017.09.009_bib0015","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/01.ju.0000157682.40869.65","article-title":"Defining recurrence after radiation for prostate cancer","volume":"173","author":"Kuban","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2017.09.009_bib0020","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jama.281.17.1598","article-title":"Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis","volume":"281","author":"Shipley","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.purol.2017.09.009_bib0025","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1200\/JCO.2002.03.061","article-title":"Determinants of prostate cancer specific survival after radiation therapy for patients with clinicallylocalized prostate cancer","volume":"20","author":"D\u2019Amico","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2017.09.009_bib0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0360-3016(00)00637-4","article-title":"Post radiotherapy prostate biopsies: what do they really mean? Results in 498\u00a0patients","volume":"48","author":"Crook","year":"2000","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"10.1016\/j.purol.2017.09.009_bib0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0360-3016(02)02977-2","article-title":"Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial","volume":"54","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.purol.2017.09.009_bib0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0360-3016(01)02778-X","article-title":"Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era","volume":"52","author":"Kupelian","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.purol.2017.09.009_bib0045","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archinternmed.2010.262","article-title":"Impact of biochemical recurrence in prostate cancer among US veterans","volume":"170","author":"Uchio","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.purol.2017.09.009_bib0050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.canrad.2010.07.222","article-title":"Salvage treatments for prostatic radiation failure","volume":"14","author":"Baumert","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.purol.2017.09.009_bib0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2008.08.063","article-title":"Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology","volume":"55","author":"Langenhuijsen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2017.09.009_bib0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.juro.2008.04.005","article-title":"Salvage prostate cryoablation: initial results from the cryo on line data registry","volume":"180","author":"Pisters","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2017.09.009_bib0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/bju.12151","article-title":"Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy","volume":"112","author":"De Castro Abreu","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2017.09.009_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2012.07.008","article-title":"Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre","volume":"64","author":"Wenske","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2017.09.009_bib0075","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.1111\/j.1464-410X.2012.11695.x","article-title":"Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: anovel risk stratification model","volume":"112","author":"Spiess","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2017.09.009_bib0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2010.12.012","article-title":"Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer","volume":"60","author":"Williams","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2017.09.009_bib0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1464-410X.2007.07045.x","article-title":"Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first100\u00a0patients","volume":"100","author":"Ismail","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2017.09.009_bib0090","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.urology.2008.03.040","article-title":"Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure","volume":"72","author":"Eisenberg","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.purol.2017.09.009_bib0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1464-410X.2011.10659.x","article-title":"Achieving the \u201cbifecta\u201d using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data","volume":"110","author":"Spiess","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2017.09.009_bib0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000332220","article-title":"Third-generation salvage cryotherapy for radiorecurrent prostate cancer: a centre's experience","volume":"88","author":"Philippou","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.purol.2017.09.009_bib0105","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.juro.2007.05.137","article-title":"Salvage cryoablation of the pros-tate: follow-up and analysis of predictive factors for outcome","volume":"178","author":"Ng","year":"2007","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.purol.2017.09.009_bib0110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.canrad.2014.04.002","article-title":"Cryoth\u00e9rapie de rattrapage apr\u00e8s radioth\u00e9rapie prostatique: principes, indications, s\u00e9lection des patients, r\u00e9sultats oncologiques et morbidit\u00e9","volume":"18","author":"H\u00e9tet","year":"2014","journal-title":"Cancer Radiother"},{"issue":"7","key":"10.1016\/j.purol.2017.09.009_bib0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1464-410X.2006.06073.x","article-title":"Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease","volume":"9","author":"Cresswell","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2017.09.009_bib0120","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cncr.22941","article-title":"Patient selection, cancer control, and complications after salvage local therapy for postra- diation prostate-specific antigen failure: a systematic review of the literature","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2017.09.009_bib0125","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.eururo.2008.04.091","article-title":"Midterm results demonstrate salvage high intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer","volume":"55","author":"Murat","year":"2009","journal-title":"Eur Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708717305432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708717305432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:30:12Z","timestamp":1761114612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708717305432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1166708717305432"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2017.09.009","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryoth\u00e9rapie prostatique de rattrapage apr\u00e8s \u00e9chec de radioth\u00e9rapie externe ou curieth\u00e9rapie\u00a0: morbidit\u00e9 et r\u00e9sultats oncologiques \u00e0 moyen terme","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2017.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}